Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials

Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials

Background: Chinese patent medicines (CMPs) have curative effectiveness in preventing coronary restenosis. However, the relative efficacy between different CPMs has not been sufficiently investigated.Methods: Randomized clinical trials were searched from electronic databases including PubMed, Web of...

Full description

Bibliographic Details
Main Authors:	Jiasai Fan, Tianli Li, Fenglan Pu, Nan Guo, Jing Wang, Yuqian Gao, Hongbing Zhao, Xian Wang, Haiyan Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Pharmacology
Subjects:	Chinese patent medicines restenosis percutaneous coronary intervention efficacy Bayesian network meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1265766/full

Similar Items

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021-11-01)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
by: Waseem Raja, et al.
Published: (2020-12-01)

Analysis of influencing factors for restenosis after percutaneous transluminal angioplasty in hemodialysis patients
by: Shen Zhan, et al.
Published: (2024-03-01)

Oral Health of Patients Undergoing Percutaneous Coronary Intervention—A Possible Link between Periodontal Disease and In-Stent Restenosis
by: Ferenc Tamás Nagy, et al.
Published: (2023-04-01)

Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis
by: Ayman Elbadawi, et al.
Published: (2023-07-01)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
by: Jiqiang Guo, et al.
Published: (2022-05-01)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
by: Hyung Joon Joo, et al.
Published: (2018-06-01)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017-12-01)

Patient profile and results of percutaneous transvenous mitral commissurotomy in mitral restenosis following prior percutaneous transvenous mitral commissurotomy vs surgical commissurotomy
by: Kamal H. Sharma, et al.
Published: (2014-03-01)

Variables asociadas a reestenosis clínica en pacientes con intervencionismo coronario percutáneo con stent convencional. Variables related to clinic restenosis in patients after percutaneous coronary interventionism with conventional stent.
by: Liz Álvarez González, et al.
Published: (2011-01-01)

Postoperative Outcomes of Mitral Valve Repair for Mitral Restenosis after Percutaneous Balloon Mitral Valvotomy
by: Seong Lee, et al.
Published: (2015-10-01)

Stabilization of a slipping balloon during the treatment of in-stent severe restenosis - anchoring the balloon shaft in the guiding catheter
by: Ali Rıza Akyüz, et al.
Published: (2014-06-01)

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review
by: AN Jingjing, WANG Xiaojuan, DENG Aiyun
Published: (2023-03-01)

Relationship between ALDH2 genotype and in-stent restenosis in Chinese Han patients after percutaneous coronary intervention
by: Lizhi Lv, et al.
Published: (2019-07-01)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
by: Gábor Csató, et al.
Published: (2022-07-01)

Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study
by: Ling Zhang, et al.
Published: (2021-09-01)

Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention
by: Cheng-Ping Hu, et al.
Published: (2018-01-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

Coronary CT Angiography- Based Assessment of Coronary in-Stent Restenosis: A Journey through Past and Present Trends
by: Yoon Seong Lee, et al.
Published: (2024-03-01)

Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia
by: Elvira V. Sobolevskaya, et al.
Published: (2023-05-01)

Prevalence, predictors, and management for balloon uncrossable or undilatable lesions in patients undergoing percutaneous coronary intervention with in-stent restenosis chronic total occlusion
by: Yong Wang, et al.
Published: (2023-05-01)

Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience
by: Anis Ghariani, et al.
Published: (2022-05-01)

Procedural Results and Long-Term Outcomes of Percutaneous Coronary Intervention for in-Stent Restenosis Chronic Total Occlusion Compared with de novo Chronic Total Occlusion
by: Tang G, et al.
Published: (2021-09-01)

Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China
by: Mingrui Li, et al.
Published: (2022-01-01)

Refractory In-Stent Restenosis Attributable to Eruptive Calcified Nodule
by: Hiroki Nakano, MD, et al.
Published: (2020-10-01)

Postangioplasty restenosis: a practical model in the porcine carotid artery
by: P.R.A. Caramori, et al.
Published: (1997-09-01)

Patent Quality and Pro-patent Policy
by: Koki Arai
Published: (2010-11-01)

The many roles of cathepsins in restenosis
by: Hai Long Wang, et al.
Published: (2024-02-01)

The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do
by: Pengfei Wang, et al.
Published: (2020-12-01)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005-10-01)

Association of the DNA Methyltransferase and Folate Cycle Enzymes’ Gene Polymorphisms with Coronary Restenosis
by: Kalima B. Timizheva, et al.
Published: (2022-02-01)

A new predictor of in-stent restenosis in patients undergoing elective percutaneous coronary İntervention: triglyceride glucose İndex
by: Muhsin Kalyoncuoglu, et al.
Published: (2021-01-01)

The percutaneous treatment of Patent Foramen Ovale, an effective and safe therapeutic choice
by: Evola S., et al.
Published: (2013-10-01)

Cerebral vascular collateral circulation assessment for restenosis after cerebrovascular intervention
by: Xixi Han, et al.
Published: (2022-01-01)

Patenting human genes: Chinese academic articles’ portrayal of gene patents
by: Li Du
Published: (2018-04-01)

Percutaneous closure of patent foramen ovale and atrial septal defect
by: Maja Rojko, MD, et al.
Published: (2020-01-01)

Predictive Value of COPD History on In-Stent Restenosis in Coronary Arteries Following Percutaneous Coronary Intervention
by: Hou L, et al.
Published: (2023-08-01)

Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
by: Chen Die Yang, et al.
Published: (2020-09-01)

Transesophageal echocardiography-guided percutaneous patent ductus arteriosus closure without fluoroscopy
by: Gang Wang, et al.
Published: (2023-04-01)

Restenosis of the femoropopliteal artery after percutaneous transluminal angioplasty
by: Vladka Salapura, et al.
Published: (2014-05-01)